1-15 of 15
You Lu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT255: AdvanTIG-204: A phase 2, multicenter, randomized, 3-arm, open-label study investigating the preliminary efficacy and safety of ociperlimab (anti-TIGIT) + tislelizumab (anti-PD-1) + concurrent chemoradiotherapy (cCRT) in patients with untreated limited-stage small cell lung cancer (SCLC)

Youling Gong, Qingsong Pang, Rong Yu, Zhengfei Zhu, Jiangqiong Huang, Yufeng Cheng, Diansheng Zhong, Hongbo Wu, Seung Soo Yoo, Tracy Dobbs, Zinan Bao, Yunxia Zuo, Boxian Wei, Pu Sun, You Lu
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT255.
https://doi.org/10.1158/1538-7445.AM2024-CT255
Published: 05 April 2024
View article titled, Abstract CT255: AdvanTIG-204: A phase 2, multicenter, randomized, 3-arm, open-label study investigating the preliminary efficacy and safety of ociperlimab (anti-TIGIT) + tislelizumab (anti-PD-1) + concurrent chemoradiotherapy (cCRT) in patients with untreated limited-stage small cell lung cancer (SCLC)
Journal Articles

Abstract CT219: Efficacy and safety of Low dose radiotherapy (LDRT) concurrent Atezolizumab (Atezo) plus chemotherapy as first line (1L) therapy for ES-SCLC: Primary analysis of Phase II MATCH study

Lin Zhou, Jianguo Sun, Conghua Xie, Youling Gong, Meijuan Huang, Zhiyong Yuan, Lin Wu, Hui Wang, Nan Bi, Yaping Xu, Jiang Zhu, Yongmei Liu, Yan Zhang, Min Fan, Bingwen Zou, Min Yu, Yanying Li, Feifei Na, Weigang Xiu, Yong Xu, Jin Wang, Xuanwei Zhang, Jianxin Xue, You Lu
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT219.
https://doi.org/10.1158/1538-7445.AM2023-CT219
Published: 14 April 2023
View article titled, Abstract CT219: Efficacy and safety of Low dose radiotherapy (LDRT) concurrent Atezolizumab (Atezo) plus chemotherapy as first line (1L) therapy for ES-SCLC: Primary analysis of Phase II MATCH study
Journal Articles

Abstract 5569: CAR-T cells with αPDL1/CD28 switch-receptor synergize radiotherapy and anti-PD1 therapy in solid tumors

Limei Yin, Wenbo Wang, Zhuoran Yao, Jianxin Xue, Ruizhan Tong, Hui Wang, Shuangsi Liao, Laduona Wang, Yue Zheng, Feifei Na, Min Yu, Xuanwei Zhang, Youling Gong, Meijuan Huang, Xianming Mo, Chong Chen, You Lu
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5569.
https://doi.org/10.1158/1538-7445.AM2022-5569
Published: 15 June 2022
View article titled, Abstract 5569: CAR-T cells with αPDL1/CD28 switch-receptor synergize radiotherapy and anti-PD1 therapy in solid tumors
Journal Articles

Abstract CT510: A phase I clinical trial of 3D-pluripotent stem cell biologics in heavily treated advanced NSCLC patients

Meijuan Huang, Xiancheng Chen, Yi Qin, Yaling Long, Qian Li, Yanna Zhang, Min Yu, Panyan Hou, Nanxi Liu, Yanying Li, Yang Yu, Xiaojuan Zhou, Youling Gong, Ke Wang, Jiang Zhu, Feng Peng, Yongsheng Wang, You Lu, Yuquan Wei
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT510.
https://doi.org/10.1158/1538-7445.AM2022-CT510
Published: 15 June 2022
View article titled, Abstract CT510: A phase I clinical trial of 3D-pluripotent stem cell biologics in heavily treated advanced NSCLC patients
Journal Articles

Abstract CT190: A multicenter, open-label, single-arm, phase II study: The third generation EGFR tyrosine kinase inhibitor almonertinib for pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (APOLLO)

Shun Lu, Qiming Wang, Guojun Zhang, Xiaorong Dong, Cheng-Ta Yang, Yong Song, Gee-Chen Chang, You Lu, Hongming Pan, Chao-Hua Chiu, Zhehai Wang, Jifeng Feng, Jianying Zhou, Xingxiang Xu, Renhua Guo, Jianhua Chen, Haihua Yang, Yuan Chen, Zhuang Yu, Her-Shyong Shiah, Chin-Chou Wang, Nong Yang, Jian Fang, Ping Wang, Kai Wang, Yanping Hu, Jianxing He, Ziping Wang, Jianhua Shi, Shaoshui Chen, Qiong Wu, Changan Sun, Chuan Li, Hongying Wei, Ying Cheng, Wu-Chou Su, Te-Chun Hsia, Jiuwei Cui, Yuping Sun, James Chih-Hsin Yang
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT190.
https://doi.org/10.1158/1538-7445.AM2020-CT190
Published: 15 August 2020
View article titled, Abstract CT190: A multicenter, open-label, single-arm, phase II study: The third generation EGFR tyrosine kinase inhibitor almonertinib for pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (APOLLO)
Journal Articles

Abstract CT114: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study

Yi-Long Wu, Shun Lu, Ying Cheng, Caicun Zhou, Jie Wang, Tony Mok, Li Zhang, Haiyan Tu, Lin Wu, Jifeng Feng, Yiping Zhang, Alexander Valeriercich Luft, Jianying Zhou, Zhiyong Ma, You Lu, Chengping Hu, Yuankai Shi, Christine Baudelet, Zoe Li, Jianhua Chang
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT114.
https://doi.org/10.1158/1538-7445.AM2018-CT114
Published: 01 July 2018
View article titled, Abstract CT114: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study
Journal Articles

Abstract CT133: A phase I trial of PD-1 deficient engineered T cells with CRISPR/Cas9 in patients with advanced non-small cell lung cancer with PD-L1 expression

You Lu, Meijuan Huang, Tao Deng, Xiaojuan Zhou, Kun Yu, Maozhi Liang, Lei Deng, Jianxin Xue, Xin Yi, Zhenyu Ding, Youling Gong, Jiang Zhu, Yongsheng Wang, Yuqi Wang, Jin Song, Ruizhan Tong, Li Li, Jingwen Huang, Feifei Na, Min Zhao, Chong Chen, Yuquan Wei, Weimin Li
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT133.
https://doi.org/10.1158/1538-7445.AM2018-CT133
Published: 01 July 2018
View article titled, Abstract CT133: A phase I trial of PD-1 deficient engineered T cells with CRISPR/Cas9 in patients with advanced non-small cell lung cancer with PD-L1 expression
Journal Articles

Abstract 5847: SIRT1 protects against radiation-induced lung injury via de-acetylating the Ku70 and P65

Jianxin Xue, Lin Zhou, Feifei Na, Lei Deng, Jie Lan, Bo Lu, Adam Dicker, You Lu
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5847.
https://doi.org/10.1158/1538-7445.AM2017-5847
Published: 01 July 2017
View article titled, Abstract 5847: SIRT1 protects against radiation-induced lung injury via de-acetylating the Ku70 and P65
Journal Articles

Abstract 769: Matched-pair comparisons of chemotherapy plus bevacizumab versus chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer

Binbin Hu, You Lu, Xiaojuan Zhou, Qian Li, Mengmeng Xiang
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 769.
https://doi.org/10.1158/1538-7445.AM2017-769
Published: 01 July 2017
View article titled, Abstract 769: Matched-pair comparisons of chemotherapy plus bevacizumab versus chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer
Journal Articles

Abstract 3671: Anti-PD-1 treatment may potentiate the radiation-induced lung injury

Jianxin Xue, Shisuo Du, You Lu, Adam Dicker, Bo Lu
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3671.
https://doi.org/10.1158/1538-7445.AM2017-3671
Published: 01 July 2017
View article titled, Abstract 3671: Anti-PD-1 treatment may potentiate the radiation-induced lung injury
Journal Articles

Abstract 2233: The fatty acid amide hydrolase inhibitor URB937 ameliorates radiation-induced lung injury in a mouse model

Rui Li, Jianxin Xue, You Lu
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2233.
https://doi.org/10.1158/1538-7445.AM2017-2233
Published: 01 July 2017
View article titled, Abstract 2233: The fatty acid amide hydrolase inhibitor URB937 ameliorates radiation-induced lung injury in a mouse model
Journal Articles

Abstract 3322: Adding pericyte inhibition to combined anti-angiogenesis and irradiation slows tumor growth but increases metastasis in mice model

Lei Deng, Jiazhuo He, Jianxin Xue, Jie Lan, Lin Zhou, Yongmei Liu, You Lu
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3322.
https://doi.org/10.1158/1538-7445.AM2015-3322
Published: 01 August 2015
View article titled, Abstract 3322: Adding pericyte inhibition to combined anti-angiogenesis and irradiation slows tumor growth but increases metastasis in mice model
Journal Articles

Active Immunogene Therapy of Cancer with Vaccine On the Basis of Chicken Homologous Matrix Metalloproteinase-2

Jing-Mei Su, Yu-Quan Wei, Ling Tian, Xia Zhao, Li Yang, Qiu-Ming He, Yu Wang, You Lu, Yang Wu, Fen Liu, Ji-Yan Liu, Jin-Liang Yang, Yan-Yan Lou, Bing Hu, Ting Niu, Yan-Jun Wen, Fei Xiao, Hong-Xin Deng, Jiong Li, Bing Kan
Journal: Cancer Research
Cancer Res (2003) 63 (3): 600–607.
Published: 01 February 2003
View article titled, Active Immunogene Therapy of Cancer with Vaccine On the Basis of Chicken Homologous Matrix Metalloproteinase-2
Open the PDF for Active Immunogene Therapy of Cancer with Vaccine On the Basis of Chicken Homologous Matrix Metalloproteinase-2 in another window
Journal Articles

The Human Homologue for the Caenorhabditis elegans cul-4 Gene Is Amplified and Overexpressed in Primary Breast Cancers

Ling-Chun Chen, Sharmila Manjeshwar, You Lu, Dan Moore, Britt-Marie Ljung, Wen-Lin Kuo, Shanaz H. Dairkee, Meredith Wernick, Colin Collins, Helene S. Smith
Journal: Cancer Research
Cancer Res (1998) 58 (16): 3677–3683.
Published: 01 August 1998
View article titled, The Human Homologue for the <em>Caenorhabditis elegans cul-4</em> Gene Is Amplified and Overexpressed in Primary Breast Cancers
Open the PDF for The Human Homologue for the <em>Caenorhabditis elegans cul-4</em> Gene Is Amplified and Overexpressed in Primary Breast Cancers in another window
Journal Articles

Contiguous Patches of Normal Human Mammary Epithelium Derived from a Single Stem Cell: Implications for Breast Carcinogenesis

Yvonne C. Tsai, You Lu, Peter W. Nichols, Galina Zlotnikov, Peter A. Jones, Helene S. Smith
Journal: Cancer Research
Cancer Res (1996) 56 (2): 402–404.
Published: 01 January 1996
View article titled, Contiguous Patches of Normal Human Mammary Epithelium Derived from a Single Stem Cell: Implications for Breast Carcinogenesis
Open the PDF for Contiguous Patches of Normal Human Mammary Epithelium Derived from a Single Stem Cell: Implications for Breast Carcinogenesis in another window